SPONSOR
Genmab
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 3, Phase 1, Phase 2
Conditions studied: Solid TumoursPlatinum-Sensitive Ovarian CancerOvarian CancerHigh Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube CancerEndometrial CancerNon-small Cell Lung CancerEpidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
Genmab is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Solid Tumours, Platinum-Sensitive Ovarian Cancer, Ovarian Cancer, High Grade Epithelial Ovarian Cancer.
The trial portfolio spans Phase 1, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Genmab
How many clinical trials has Genmab sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Genmab, of which 3 are actively recruiting participants. These trials cover conditions including Solid Tumours, Platinum-Sensitive Ovarian Cancer, Ovarian Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Genmab research focus on?
Genmab clinical trials span Solid Tumours, Platinum-Sensitive Ovarian Cancer, Ovarian Cancer, High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Genmab clinical trial?
To participate in a Genmab trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Genmab trials with current recruitment status updated daily.
Clinical Trials by Genmab
NCT07695831 Phase 1
Recruiting
A Phase 1 Trial of GEN1119 in Participants With Solid Tumors
Solid Tumours
NCT07564141 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
Platinum-Sensitive Ovarian Cancer
NCT05579366 Phase 1, Phase 2
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
High Grade Epithelial Ovarian Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology